Currently, there are 209.44M common shares owned by the public and among those 178.25M shares have been available to trade.
The company’s stock has a 5-day price change of -16.73% and 134.78% over the past three months. HIMS shares are trading 103.80% year to date (YTD), with the 12-month market performance up to 412.80% higher. It has a 12-month low price of $9.22 and touched a high of $72.98 over the same period. HIMS has an average intraday trading volume of 15.56 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 9.60%, 41.57%, and 108.38% respectively.
Institutional ownership of Hims & Hers Health Inc (NYSE: HIMS) shares accounts for 74.94% of the company’s 209.44M shares outstanding.
It has a market capitalization of $10.77B and a beta (3y monthly) value of 1.40. The stock’s trailing 12-month PE ratio is 113.99, while the earnings-per-share (ttm) stands at $0.43. Price movements for the stock have been influenced by the stock’s volatility, which stands at 14.63% over the week and 10.91% over the month.
Earnings per share for the fiscal year are expected to increase by 590.70%, and 0.88% over the next financial year.
Looking at the support for the HIMS, a number of firms have released research notes about the stock. Morgan Stanley stated their Equal-Weight rating for the stock in a research note on February 18, 2025, with the firm’s price target at $42-$60. Citigroup coverage for the Hims & Hers Health Inc (HIMS) stock in a research note released on January 10, 2025 offered a Sell rating with a price target of $25. BTIG Research was of a view on January 07, 2025 that the stock is Buy, while Morgan Stanley gave the stock Overweight rating on December 17, 2024, issuing a price target of $42. BofA Securities on their part issued Underperform rating on November 14, 2024.
